Search

Your search keyword '"Lermine A"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Lermine A" Remove constraint Author: "Lermine A"
47 results on '"Lermine A"'

Search Results

1. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

4. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1

5. DOT1L regulates chromatin reorganization and gene expression during sperm differentiation

7. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

8. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

9. The histone methyltransferase DOT1L regulates chromatin reorganization and gene expression during the postmeiotic differentiation of male germ cells

10. Additional file 1 of Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

11. Pros and cons of HaloPlex enrichment in cancer predisposition genetic diagnosis

12. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

13. DOT1L regulates chromatin reorganization and gene expression during sperm differentiation

14. The histone methyltransferase DOT1L regulates chromatin reorganization and gene expression during the postmeiotic differentiation of male germ cells

15. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1

16. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1

17. Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder

18. Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder

19. Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder

21. Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

22. Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis.

24. Développement d’un panel « Next Generation Sequencing » ciblé en vue d’améliorer la prise en charge des patients atteints de mélanome

25. Développement d’un panel « Next Generation Sequencing » ciblé en vue d’améliorer la prise en charge des patients atteints de mélanome

26. Abstract PD3-8: Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

27. Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

28. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries

29. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries

30. Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

31. Abstract 1524: Mutations and gene copy number variations landscape of metastases of various cancer types from patients enrolled in the SHIVA trial

32. Towards a cyber Galaxy ?

33. Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis

34. Toward a French cyber Galaxy ?

35. Nebula--a web-server for advanced ChIP-seq data analysis

36. The new accelerator control system of GANIL

37. Pros and cons of HaloPlex enrichment in cancer predisposition genetic diagnosis

38. Abstract PD3-8: Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

39. Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

40. Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial

41. Monitoring of circulating tumor DNA in metastatic triple-negative breast cancer patients undergoing chemotherapy.

42. Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis

45. The new accelerator control system of GANIL

46. Monitoring of circulating tumor DNA in metastatic triple-negative breast cancer patients undergoing chemotherapy

47. A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder.

Catalog

Books, media, physical & digital resources